Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine

Brain Research Bulletin

Volumn 82, Issue 1-2, 2010, Pages 18-24

  Vidal, Lourdes ^a   Díaz, Florentina ^a   Villena, Alicia ^a   Moreno, Mercedes ^a   Campos, José García ^a   Pérez de Vargas, Ignacio ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

GFAP immunoreactivity; Hypotensive drugs; Intraocular pressure; M ller cells; Reactive gliosis; Retina

Indexed keywords

BRIMONIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; LATANOPROST; PROTEIN ANTIBODY; TIMOFTOL; TIMOLOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CAUTERIZATION; CONTROLLED STUDY; EXPERIMENTAL RAT; GLIOSIS; HYPERTROPHY; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; INTRAOCULAR PRESSURE ABNORMALITY; MALE; MUELLER CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; TISSUE SECTION; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; GLAUCOMA; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; INTRAOCULAR PRESSURE; MALE; NEUROGLIA; PROSTAGLANDINS F, SYNTHETIC; QUINOXALINES; RATS; RATS, WISTAR; RETINA; TIMOLOL; TONOMETRY, OCULAR;

EID: 77952319595     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.02.011     Document Type: Article

References (61)

1. Akman A., Cetinkaya A., Akova Y.A., Ertan A. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination. Eye 2005, 19:145-151.
2. 2 agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure. Brain Res. 2001, 913:133-139.
3. Arai K., Wood J.P.M., Osborne N.N. β-Adrenergic receptor agonists and antagonists counteract LPS-induced neuronal death in retinal cultures by different mechanisms. Brain Res. 2003, 985:176-186.
4. Baptiste D.C., Hartwick A.T., Jollimore C.A., Baldridge W.H., Chauhan B.C., Tremblay F., Kelly M.E. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina. Invest. Ophthalmol. Vis. Sci. 2002, 43:2666-2676.
5. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S., Osborne N.N., Reichenbach A. Müller cells in the healthy and diseased retina. Prog. Retn. Eye Res. 2006, 25:397-424.
6. Cotinet A., Goureau O., Hicks D., Thillaye-Goldenberg B., De Kozak Y. Tumor necrosis factor and nitric oxide production by retinal Müller glial cells from rats exhibiting inherited retinal dystrophy. Glia 1997, 20:59-69.
7. Crowston J.G., Aihara M., Lindsey J.D., Weinreb R.N. Effect of latanoprost on outflow facility in the mouse. Invest. Ophthalmol. Vis. Sci. 2004, 45:2240-2245.
8. Cheon E.W., Park C.H., Kang S.S., Cho G.J., Yoo J.M., Song J.K., Choi W.S. Nitric oxide synthase expression in the transient ischemic rat retina: neuroprotection of betaxolol. Neurosci. Lett. 2002, 330:265-269.
9. Díaz F., Villena A., Moreno M., Vidal L., García-Campos J., Pérez de Vargas I. Effects of a non-selective β-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure. Histol. Histopathol. 2005, 20:1077-1084.
10. Fletcher E.L., Downie L.E., Ly A., Ward M.M., Batcha A.H., Puthussery T., Yee P., Hatzopoulos K.M. A review of the role of glial cells in understanding retinal disease. Clin. Exp. Optom. 2008, 91:67-77.
11. Francke M., Faude F., Pannicke T., Uckermann O., Weick M., Wolburg H., Wiedemann P., Reichenbach A., Uhlmann S., Bringmann A. Glial cell-mediated spread of retinal degeneration during detachment: a hypothesis based upon studies in rabbits. Vision Res. 2005, 45:2256-2267.
12. Frishman W.H., Fuksbrumer M.S., Tannenbaum M. Topical ophthalmic β-adrenergic blockade for the treatment of glaucoma and ocular hypertensin. J. Clin. Pharmacol. 1994, 34:795-803.
13. Gao H., Quiao X., Cantor L.B., WuDunn D. Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch. Ophthalmol. 2002, 120:797-803.
14. Garcia-Valenzuela E., Shareef S., Walsh J., Sharma S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 1995, 61:33-44.
15. Harada T., Harada C., Watanabe M., Inoue Y., Sakagaba T., Nakayama N., Sasaki S., Okuyama S., Watase K., Wada K., Tanaka K. Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:4663-4666.
16. Hernandez M., Urcola J.H., Vecino E. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Exp. Eye Res. 2008, 86:798-806.
17. Hoyng P.F., Van Beek L.M. Pharmacological therapy for glaucoma: a review. Drugs 2000, 59:411-434.
18. Inman D.M., Horner P.J. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 2007, 55:942-953.
19. Ishii Y., Kwong J.M., Caprioli J. Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 2003, 44:1982-1992.
20. Kanamori A., Nakamura M., Nakanishi Y., Yamada Y., Negi A. Long-term glial reactivity in rat retinas ipsilateral and contralateral to experimental glaucoma. Exp. Eye Res. 2005, 81:48-56.
21. Kawasaki A., Otori Y., Barnstable C.J. Müller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity. Invest. Ophthalmol. Vis. Sci. 2000, 41:3444-3450.
22. Kim I.B., Kim K.Y., Joo C.K., Lee M.Y., Oh S.J., Cheng J.W., Chum M.H. Reaction of Müller cells after increased intraocular pressure in the rat retina. Exp. Brain Res. 1998, 121:419-424.
23. Kim H.S., Park C.K. Retinal ganglion cell death is delayed by activation of retinal intrinsic cell survival program. Brain Res. 2005, 1057:17-28.
24. Kim H.S., Chang Y.I., Kim J.H., Park C.K. Alteration of retinal intrinsic survival signal and effect of α2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat. Vis. Neurosci. 2007, 24:127-139.
25. Laquis S., Chaudhary P., Sharma S.C. The patterns of retinal ganglion cell in hypertensive eyes. Brain Res. 1998, 784:100-104.
26. Levkovitch-Verbin H., Quigley H.A., Martin K.R., Valenta D., Baumrind L.A., Pease M.E. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest. Ophthalmol. Vis. Sci. 2002, 43:402-410.
27. McKinnon S.J., Goldberg L.D., Peeples P., Walt J.G., Bramley T.J. Current management of glaucoma and the need for complete therapy. Am. J. Manag. Care. 2008, 14:S20-S27.
28. Melena J., Stanton D., Osborne N.N. Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:522-530.
29. Mittag T.W., Danias J., Pohorenec G., Yuan H.-M., Burakgazi E., Chalmers-Redman R., Podos S.M., Tatton W.G. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 2000, 41:3451-3459.
30. Moore C.G., Milne S.T., Morrison J.C. Noninvasive measurement of rat intraocular pressure with Tono-Pen. Invest. Ophthalmol. Vis. Sci. 1993, 34:363-369.
31. Nakanishi Y., Nakamura M., Mukuno H., Kanamori A., Seigel G.M., Negi A. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase. Exp. Eye Res. 2006, 83:1108-1117.
32. Neufeld A.H., Hernandez M.R., Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol. 1997, 115:497-503.
33. Neufeld A.H., Sawada A., Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9944-9948.
34. Newman E.A., Reinchenbach A. The Müller cell: a functional element of the retina. Trends Neurosci. 1996, 19:307-312.
35. Osborne N.N., Block F., Sontag K.H. Reduction of ocular blood flow results in glial fibrilar acidic protein (GFAP) expression in rat retinal Müller cells. Vis. Neurosci. 1991, 7:637-639.
36. Osborne N.N., Casson R.J., Wood J.P.M., Chidlow G., Graham M., Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retn. Eye Res. 2004, 23:91-147.
37. Osborne N.N., Wood J.P.M., Chidlow G., Casson R., DeSantis L., Schmidt K.-G. Effectiveness of levobetaxolol and timolol at blunting retinal ischemia is related to their calcium and sodium blocking activities: relevance to glaucoma. Brain Res. Bull. 2004, 62:525-528.
38. Pang I.H., Wang W.H., Clark A.F. Acute effects of glaucoma medications on rat intraocular pressure. Exp. Eye Res. 2005, 80:207-214.
39. Quigley H.A. Open-angle glaucoma. New Engl. J. Med. 1993, 328:1097-1106.
40. Reichenbach A., Wurn A., Pannicke T., Iandiev I., Wiedemann P., Bringmann A. Müller cells as players in retinal degeneration and edema. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245:627-636.
41. Seki M., Tanaka T., Matsuda H., Togano T., Hashimoto K., Ueda J., Fukuchi T., Abe H. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model. Br. J. Ophthalmol. 2005, 89:504-507.
42. Shareef S.R., Garcia-Valenzuela E., Salieron A., Walsh J., Sharma S.C. Chronic ocular hypertension following episcleral venous occlusion in rats (letter). Exp. Eye Res. 1995, 61:379-382.
43. Tamaki Y., Nagahara M., Araie M., Tomita K., Sandoh S., Tomidokoro A. Topical latanoprost and optic nerve head and retinal circulation in humans. J. Ocul. Pharmacol. Ther. 2001, 17:403-411.
44. Tanihara H., Hangai M., Sawaguchi S., Abe H., Kajeyama M., Nakazawa F., Shirasawa E., Honda Y. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma. Arch. Ophthalmol. 1997, 115:752-756.
45. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retn. Eye Res. 2006, 25:490-513.
46. Tezel G., Chauhan B.C., LeBlanc R.P., Wax M.B. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Invest. Ophthalmol. Vis. Sci. 2003, 44:3025-3033.
47. Tezel G., Hernandez M.R., Wax M.B. In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head. Glia 2001, 34:178-189.
48. Tezel G., Wax M.B. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci. 2000, 20:8693-8700.
49. Tezel G., Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest. Ophthalmol. Vis. Sci. 2004, 45:4049-4059.
50. Varela H.J., Hernandez M.R. Astrocyte responses in human optic nerve head with primary open-angle glaucoma. J. Glaucoma 1997, 6:303-313.
51. Vidal L., Diaz F., Villena A., Moreno M., Garcia-Campos J., Perez de Vargas I. Nitric oxide synthase in retina and optic nerve head of rat with increased intraocular pressure and effect of timolol. Brain Res. Bull. 2006, 70:406-413.
52. Villena A., Díaz F., Vidal L., Moreno M., García-Campos J., Pérez de Vargas I. Study of the effects of ocular hypotensive drugs on number of neurons in the retinal ganglion layer in a rat experimental glaucoma. Eur. J. Ophthalmol. 2009, 19:963-970.
53. Wang X., Ng Y.K., Tay S.W. Factors contributing to neuronal degeneration in retinas of experimental glaucomatous rats. J. Neurosci. Res. 2005, 82:674-689.
54. Wang X., Tay S.S., Ng Y.K. An immunohistochemical study of neuronal and glial cells reactions in retinae of rats with experimental glaucoma. Exp. Brain Res. 2000, 132:476-484.
55. Wang X., Tay S.S., Ng Y.K. An electron microscopic study of neural degeneration and glial cell reaction in the retina of glaucomatous rats. Histol. Histopathol. 2002, 17:1043-1052.
56. Whitson J.T., Henry C., Hughes B., Lee D.A., Terry S., Fechtner R.D. Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertensive. J. Glaucoma 2004, 13:168-173.
57. Woldemussie E., Ruiz G., Wijono M., Wheeler L. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest. Ophthalmol. Vis. Sci. 2001, 42:2849-2855.
58. Woldemussie E., Wijono M., Ruiz G. Müller cell response to laser-induced increase in intraocular pressure in rats. Glia 2004, 47:109-119.
59. Wood J.P.M., Schmidt K.G., Melena J., Chidlow G., Allmeier H., Osborne N.N. The β-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp. Eye Res. 2003, 76:505-516.
60. Yamamoto H., Schmidt-Kastner R., Hamasaki D.I., Yamamoto H., Parel J.M. Complex neurodegeneration in retina following moderate ischemia induced by bilateral common carotid artery occlusion in Wistar rats. Exp. Eye Res. 2006, 82:767-779.
61. Zhang J., Wu S.M., Gross R.L. Effects of β-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells. Brain Res. 2003, 959:111-119.